Sources | Names Used |
---|---|
CTRPv2 | BRD-K27188169:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-K27188169:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ELP2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | CCNJ | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | SSBP2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | C11orf84 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | PHF8 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | HPCA | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | EPB41L4B | CTRPv2 | pan-cancer | AAC | -0.15 | 0.01 |
mRNA | MYB | CTRPv2 | pan-cancer | AAC | 0.15 | 0.01 |
mRNA | DDX25 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | FAM209B | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |